The DOI matches its Crossref record.
Increased Bone Adiposity and Peroxisomal Proliferator-Activated Receptor-γ2 Expression in Type I Diabetic Mice
Open accessAbstract
Decreased bone mass, osteoporosis, and increased fracture rates are common skeletal complications in patients with insulin-dependent diabetes mellitus (IDDM; type I diabetes). IDDM develops from little or no insulin production and is marked by elevated blood glucose levels and weight loss. In this study we use a streptozotocin-induced diabetic mouse model to examine the effect of type I diabetes on bone. Histology and microcomputed tomography demonstrate that adult diabetic mice, exhibiting increased plasma glucose and osmolality, have decreased trabecular bone mineral content compared with controls. Bone resorption could not completely account for this effect, because resorption markers (tartrate-resistant acid phosphatase 5b, urinary deoxypyridinoline excretion, and tartrate-resistant acid phosphatase 5 mRNA) are unchanged or reduced at 2 and/or 4 wk after diabetes induction. However, osteocalcin mRNA (a marker of late-stage osteoblast differentiation) and dynamic parameters of bone formation were decreased in diabetic tibias, whereas osteoblast number and runx2 and alkaline phosphatase mRNA levels did not differ. These findings suggest that the final stages of osteoblast maturation and function are suppressed. We also propose a second mechanism contributing to diabetic bone loss: increased marrow adiposity. This is supported by increased expression of adipocyte markers [peroxisome proliferator-activated receptor gamma2, resistin, and adipocyte fatty acid binding protein (alphaP2)] and the appearance of lipid-dense adipocytes in diabetic tibias. In contrast to bone marrow, adipose stores at other sites are depleted in diabetic mice, as indicated by decreased body, liver, and peripheral adipose tissue weights. These findings suggest that IDDM contributes to bone loss through changes in marrow composition resulting in decreased mature osteoblasts and increased adipose accumulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Mechanisms of Disease: is osteoporosis the obesity of bone?
Rosen, C. J., & Bouxsein, M. L. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0070 · Cited by 956
A comprehensive overview on osteoporosis and its risk factors
Pouresmaeili, F., Kamali Dehghan, B., Kamarehei, M., & Yong Meng, G. (2018) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s138000 · Cited by 597
Understanding the Bone in Cancer Metastasis
Fornetti, J., Welm, A. L., & Stewart, S. A. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3618 · Cited by 526
Gimble, J. M., Zvonic, S., Floyd, Z. E., Kassem, M., & Nuttall, M. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20777 · Cited by 495
Bone fragility in diabetes: novel concepts and clinical implications
Hofbauer, L. C., Busse, B., Eastell, R., Ferrari, S., Frost, M., Müller, R., Burden, A. M., Rivadeneira, F., Napoli, N., & Rauner, M. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00347-8 · Cited by 440
Marrow Fat and Bone—New Perspectives
Fazeli, P. K., Horowitz, M. C., MacDougald, O. A., Scheller, E. L., Rodeheffer, M. S., Rosen, C. J., & Klibanski, A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3634 · Cited by 416
Bone, sweet bone—osteoporotic fractures in diabetes mellitus
Hamann, C., Kirschner, S., Günther, K.-P., & Hofbauer, L. C. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.233 · Cited by 380
Bone Loss and Increased Bone Adiposity in Spontaneous and Pharmacologically Induced Diabetic Mice
Botolin, S., & McCabe, L. R. (2007) · Endocrinology · doi:10.1210/en.2006-1006 · Cited by 266
Self-citationThe bone–fat interface: basic and clinical implications of marrow adiposity
Devlin, M. J., & Rosen, C. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70007-5 · Cited by 255
Okazaki, K., Yamaguchi, T., Tanaka, K.-I., Notsu, M., Ogawa, N., Yano, S., & Sugimoto, T. (2012) · Calcified Tissue International · doi:10.1007/s00223-012-9641-2 · Cited by 98
Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice
Rubin, M. R., Paschalis, E. P., Poundarik, A., Sroga, G. E., McMahon, D. J., Gamsjaeger, S., Klaushofer, K., & Vashishth, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154700 · Cited by 90
“Although type 1 and type 2 diabetes affect bone architecture [32, 33] and remodeling [34, 35], the accumulation of AGEs in bone organic matrix also correlates with biomechanical weakness [36].”
Implant Healing in Experimental Animal Models of Diabetes
Le, N. N., Rose, M. B., Levinson, H., & Klitzman, B. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500315 · Cited by 52
Sadie-Van Gijsen, H., Hough, F. S., & Ferris, W. F. (2013) · Bone · doi:10.1016/j.bone.2013.06.016 · Cited by 48
Zhang, X., Tian, L., Majumdar, A., & Scheller, E. L. (2024) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2024.tb00300.x · Cited by 18
Metadata
- Authors
- Botolin, S., Faugere, M.-C., Malluche, H., Orth, M., Meyer, R., & McCabe, L. R.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-08
- Volume
- 146
- Issue
- 8
- Pages
- 3622-3631
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2032107044
- Cited by
- 229
- References
- 0
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.